NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Drug Industry Remove constraint Subjects: Drug Industry Genre Guideline Remove constraint Genre: Guideline

Search Results

12. Compounding certain ibuprofen oral suspension products under section 503B of the Federal Food, Drug, and Cosmetic Act

19. Presenting quantitative efficacy and risk information in direct-to-consumer (DTC) promotional labeling and advertisements: guidance for industry